Lifotronic
Shenzhen Lifotronic Technology is a Chinese medical device company that develops IVD analyzers (ECLIA, HPLC, hematology, POCT, molecular), clinical treatment equipment, aesthetic laser platforms, and consumer health products for hospitals and clinics in 120+ countries.
- Company typePublic
- Founded2008
- HeadquartersShenzhen, China
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Lifotronic does
Shenzhen Lifotronic Technology Co., Ltd. (深圳普门科技股份有限公司) is a Chinese medical device company founded in 2008 in Shenzhen and listed on the Shanghai Stock Exchange STAR Market (科创板) on November 5, 2019 under stock code 688389. The company operates a dual-engine model combining R&D-driven innovation with global marketing, organized into four product divisions: In Vitro Diagnostics (IVD), Clinical Healthcare, Aesthetic Medicine, and Consumer Health. Underlying technology platforms include electrochemiluminescence immunoassay (ECLIA, eCL9000/eCL8600/ECL8000), HPLC hemoglobin analysis (H100/H100Plus, H9, H8, GH-900Plus), 5-part and 3-part hematology analysis (AC610, AC310), POCT immunofluorescence (FA-160/FA-218), and molecular diagnostics (PureStar-32 nucleic acid extractor, GeneStar-96 real-time PCR) plus rapid infectious disease test kits. The clinical division covers respiratory humidification (Hi-800), HFCWO airway clearance (PV-900), ESWT pain management, video laryngoscopy, and patient warming. The aesthetic division spans diode laser hair removal (Metis T60A), fractional CO2 lasers, Q-switched Nd:YAG lasers, IPL, and HIFU devices. Consumer Health products include the Aladdin-E photon therapy instrument for home use.
The company monetizes primarily through hardware sales of medical devices and recurring IVD reagent and consumable pull-through (ECLIA reagents, HPLC columns and reagents, hematology reagents) across an installed base of 24,000+ Chinese hospitals including 2,800+ tier-3 hospitals. Distribution combines direct sales to hospitals in China, wholly owned overseas subsidiaries in Hong Kong (2015), Macau (2022), Russia (2022), and Indonesia (2022) covering business contacts in 80+ countries, an international distributor network spanning 120+ countries, and direct-to-consumer e-commerce via official online store, JD.com, and Tmall flagship stores. Marketing relies heavily on global trade show participation (MEDICA, Arab Health, Medlab, AACC, CMEF, WHX Labs) and recently formalized strategic supply and co-development partnerships with QuidelOrtho China for immunoassay market expansion and Sysmex Japan for global IVD. Recognized as a National High-Tech Enterprise, Specialized and Innovative 'Little Giant', and recipient of the 2015 National Science and Technology Progress Award (First Class), the company operates seven technology innovation platforms including a national Academician Workstation and has executed 40+ national/provincial R&D and industrialization projects.
Lifotronic firmographics
Firmographics- Name
- Lifotronic
- Legal name
- 深圳普门科技股份有限公司
- Website
- https://lifotronic.com
- Company type
- Public
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Shenzhen Lifotronic Technology is a Chinese medical device company that develops IVD analyzers (ECLIA, HPLC, hematology, POCT, molecular), clinical treatment equipment, aesthetic laser platforms, and consumer health products for hospitals and clinics in 120+ countries.
- Ownership category
- akta.pro rank
Lifotronic industry classification
Industry- Product category
- In Vitro Diagnostics & Medical Devices
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
- akta.pro secondary industries
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)
Keywords
Where Lifotronic is headquartered
LocationHeadquarters
- HQ city
- Shenzhen
- HQ country
- China
- HQ region
- Asia
Offices8 records
Markets served
Lifotronic business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Sale of medical devices and instruments including IVD equipment, clinical treatment devices, aesthetic laser equipment, and consumer health products
- IVD Reagents and Consumables: 配套试剂 - Reagent kits and consumables for IVD systems including ECLIA reagents, HPLC columns and reagents, hematology reagents
Go-to-market motion1 record
Distribution channels6 records
Marketing channels9 records
Lifotronic product offering
Product offeringCore offering
Lifotronic develops, manufactures, and globally markets medical devices and matching reagents across four product lines: In Vitro Diagnostics (ECLIA immunoassay, HPLC hemoglobin, hematology, POCT immunofluorescence, and molecular diagnostics systems), Clinical Treatment equipment (high-flow humidifiers, HFCWO airway clearance, ESWT, video laryngoscopy, patient warming), Medical Aesthetic lasers (CO2 fractional, Q-switched Nd:YAG, diode, HIFU), and Consumer Health phototherapy devices. The company sells complete instrument-plus-reagent solutions to hospitals, labs, and clinics.
Product overview
Lifotronic is a comprehensive medical device company offering a multi-platform portfolio spanning four major product categories: In Vitro Diagnostics (IVD), Clinical Healthcare, Aesthetic Medicine, and Consumer Health. The IVD division includes multiple analytical platforms: electrochemiluminescence immunoassay (ECLIA) systems (eCL9000/eCL8600, ECL8000) for comprehensive biomarker detection; HPLC hemoglobin analyzers (H100/H100Plus, H9, H8, GH-900Plus) for diabetes monitoring; hematology analyzers (AC610, AC310, AC610 Vet) for blood analysis; immunofluorescence analyzers (FA-160, FA-218) for point-of-care testing; molecular diagnostics (PureStar-32 nucleic acid extractor, GeneStar-96 real-time PCR); and rapid test products (COVID-19, monkeypox, dengue, malaria, influenza). The Clinical Healthcare division provides respiratory/critical care equipment (Hi-800 high-flow humidifier, PV-900 HFCWO vest), pain management (ESWT devices), video laryngoscopy, and patient warming systems. The Aesthetic division offers a complete medical-aesthetic laser portfolio including diode laser hair removal (Metis T60A), CO2 fractional lasers, Nd:YAG Q-switched lasers, IPL systems, and HIFU devices. Consumer Health products include photon therapy instruments for home use. The company operates a dual engine model combining R&D innovation with global marketing, exporting to 120+ countries with products installed in 24,000+ hospitals including 2,800 tier-3 hospitals in China.
Differentiator
Problem solved
Functional benefit
Products and services
- eCL9000/eCL8600 ECLIA Immunoassay Analyzer High-end automated electrochemiluminescence immunoassay analyzer using tris-bipyridine ruthenium label; single-module 300 tests/hour, system expandable to 1200 tests/hour, fastest 9-minute time to first result; for hospitals and clinical labs running immunoassay panels.
- ECL8000 Immunoassay Analyzer Fully automated ECLIA analyzer with 86 tests/hour throughput and 90+ parameters covering thyroid, fertility, tumor, cardiac, inflammation, and bone metabolism markers; 9-minute time to first result, 10-position cooled reagent system; for small and mid-size labs.
- H100 / H100Plus HPLC Hemoglobin Analyzer Fully automated HPLC hemoglobin analyzer delivering HbA1c results in 96 seconds with hemoglobin variant recognition; beta-thalassemia mode for variant samples; for diabetes monitoring and hemoglobinopathy screening in hospitals and labs.
- H9 HPLC Hemoglobin Analyzer Dual-function HPLC hemoglobin analyzer for HbA1c testing and hemoglobin variant detection; 110+1 STAT sample loader; 96 sec/test for variant mode; for clinical labs needing diabetes and thalassemia screening.
- H8 HPLC Hemoglobin Analyzer Fully automated HPLC HbA1c analyzer delivering 96-second results with hemoglobin variant recognition; dual-wavelength detection eliminates background interference; 10-position sample loader with STAT position.
- GH-900Plus HbA1c Analyzer Compact HPLC HbA1c analyzer providing 130-second results with hemoglobin variant recognition; CV<1.5% precision; footprint under 0.16 m² for space-constrained labs.
- AC610 5-Part Hematology Analyzer Automatic 5-part differential hematology analyzer with 3D scattergram and true triangular optical system; 60 tests/hour; impedance+optical BASO channel; 100,000-result storage; for small/medium diagnostic labs, hospitals, and clinics.
- AC310 3-Part Hematology Analyzer Automatic 3-part differential hematology analyzer with 21 parameters and 3 histograms; 60 tests/hour; compact, lower operating cost; for small/medium diagnostic labs.
- AC610 Vet Veterinary Hematology Analyzer 5-part differential hematology analyzer designed for veterinary use; compact size, lower operating cost, user-friendly operation.
- FA-160 / FA-218 Immunofluorescence Analyzers POCT immunofluorescence analyzers for quantitative determination of cardiac, infectious disease, and other analytes; FA-160 with 6 incubation channels and 10,000-result storage; FA-218 with 18 incubation channels and CV≤2%.
- PureStar-32 Nucleic Acid Extraction System Automated magnetic-bead nucleic acid extractor processing 32 samples/cycle in 10 minutes with ≥98% particle recovery; for molecular diagnostic workflows in labs.
- GeneStar-96 Real-Time PCR System Real-time PCR system with 4 fluorescence channels, 96-sample capacity; supports qualitative/quantitative, SNP, and melting-curve analysis; for high-end molecular diagnostic labs.
- Rapid Test Kits (COVID-19, Monkeypox, Dengue, Malaria, Influenza A&B) Rapid screening test kits for infectious diseases including COVID-19 antigen, monkeypox PCR, dengue, malaria, and influenza A&B; for hospitals, labs, and clinics.
- Hi-800 High-Flow Nasal Cannula Humidifier High-flow medical respiratory humidifier with intelligent temperature-flow control, automatic oxygen mixing, and 80 L/min flow rate; 5-inch touchscreen; for respiratory therapy in hospitals and ICUs.
- PV-900 High-Frequency Chest Wall Oscillation (HFCWO) System Airway clearance system using high-frequency chest wall oscillation with 4 treatment modes, 3-30 mmHg pressure, and 1-20 Hz frequency; for hospitals and rehabilitation centers treating mucus clearance.
- LC-320 / LC-560 Extracorporeal Shock Wave Therapy (ESWT) Electromagnetic ESWT devices for pain management and rehabilitation; LC-320 and LC-560 used by hospitals and clinics for pain conditions.
- TC-200 Patient Warming System Warming unit with disposable blankets to prevent perioperative hypothermia during surgery; for operating rooms.
- SmartScope VL Video Laryngoscope Video laryngoscope with high-resolution anti-fog camera and disposable blades for all ages; up to 4 million stored images; for intubation in anesthesia and emergency care.
- Metis T60A Diode Laser Hair Removal System Diode laser hair removal device with 1800W power and 4-wavelength combination (755/808/940/1064 nm) for all skin types; unlimited shot lifespan; for aesthetic clinics.
- ProFirm HIFU System High-Intensity Focused Ultrasound device for non-invasive skin lifting and tightening; for medical aesthetic clinics and dermatology centers.
- NICE-01 / SPLB-200A Fractional CO2 Laser 10600 nm fractional CO2 laser with matrix-array beam, 0.07 mm spot size, and approved indication for eyeball globe protection; 10+ years clinical track record; for dermatology and aesthetic clinics.
- MLB-200A Q-Switched Nd:YAG Laser Q-switched Nd:YAG laser with 2 ns pulse duration, 1200 mJ single pulse energy, and simultaneous 1064/532 nm emission; for tattoo removal, pigmentation, and skin rejuvenation in aesthetic clinics.
- Yucca Series CO2 Laser Treatment System CO2 laser for vaporization, carbonization, coagulation, and irradiation of tissue to treat warts, moles, sweat gland tumors, and reduce facial wrinkles via scanning mode; for dermatology clinics.
- Aladdin-E Photon Therapy Instrument Home-use photon therapy device for anti-inflammation, pain relief, and wound healing; promotes granulation tissue growth on body-surface wounds; for consumer/home health use.
- IVD Reagents and Consumables Reagents, columns, calibrators, and quality-control materials for HPLC hemoglobin analyzers and other IVD platforms (Reagent A/B/C/L, columns 1600T/1200T/800T); for hospitals and labs using Lifotronic analyzers.
Companies that use Lifotronic
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles3 records
Lifotronic technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Lifotronic partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Quick Urosun (快奥森多)coreStrategic cooperation with Quick Urosun China region to jointly develop core market opportunities. Partnership includes strategic cooperation launch at CACLP 2026 and long-term strategic supply agreement to jointly expand global immunoassay testing market.
- Sysmex Japan (日本希森美康)coreGlobal IVD strategic partnership with Sysmex Corporation, a world-renowned IVD company based in Japan. Partnership focused on IVD market solutions and technology collaboration.
Scale indicators6 records
Recent moves10 records
Expansion highlights5 records
Lifotronic competitors and assessment
Company assessmentDirect peers
- Autobio Diagnostics: Chinese IVD company specializing in chemiluminescence immunoassay, microbiology, and clinical chemistry. Comparable as a direct domestic IVD peer targeting similar hospital and laboratory customers.
- Snibe (Shenzhen New Industries Biomedical Engineering): Direct Chinese IVD competitor with proprietary MAGLUMI chemiluminescence immunoassay platform. Closely comparable on ECLIA/CLIA technology positioning, reagent menu, and global expansion strategy.
- Maccura Biotechnology: Chinese IVD player with immunoassay, clinical chemistry, hematology, and molecular diagnostics products. Comparable on multi-modality IVD portfolio and Chinese hospital go-to-market.
- Mindray (Shenzhen Mindray Bio-Medical Electronics): Largest Chinese medical device and IVD company with overlapping IVD instrument/reagent portfolio and global hospital sales coverage. Comparable as a multi-modality Chinese IVD/medical device leader with broad international reach.
Broad incumbents
- Roche Diagnostics: Global IVD market leader with cobas ECLIA and clinical chemistry platforms. Comparable as the dominant broad-line IVD incumbent whose ECLIA franchise competes directly with Lifotronic's eCL9000/eCL8600.
- Siemens Healthineers: Global medical technology and IVD company with Atellica immunoassay/clinical chemistry and ADVIA Centaur hematology. Comparable as a broad incumbent offering IVD plus adjacent imaging/diagnostics.
- Sysmex Corporation: Global leader in hematology and IVD with extensive reagent menu; Lifotronic's strategic IVD partner. Comparable as an established IVD incumbent with which Lifotronic competes in hematology (AC610) while partnering in immunoassay.
- Bio-Rad Laboratories: Clinical diagnostics and life science research company with diabetes/HbA1c monitoring and quality control products. Comparable as an incumbent in HPLC-based HbA1c testing, the same category as Lifotronic's H100/H8/H9 series.
- QuidelOrtho (Werfen/Quidel): Global immunoassay and specialty diagnostics company; Lifotronic's strategic China partner for immunoassay. Comparable as an IVD incumbent whose products overlap with Lifotronic's ECLIA menu.
- Abbott Diagnostics: Global IVD leader with Architect immunoassay and Alinity ci clinical chemistry/immunoassay systems. Comparable as a broad IVD incumbent whose installed base sets the standard for reagent menu and instrument throughput.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Lifotronic social profiles
Digital presenceLifotronic compliance and trust
Trust signalCompliance6 records
Lifotronic financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lifotronic leadership team
Management profileNumber of profiles
Profiles4 records
Lifotronic subsidiaries and ownership
Company hierarchySubsidiaries4 records
Lifotronic funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lifotronic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lifotronic
What does Lifotronic do?
Lifotronic develops, manufactures, and globally markets medical devices and matching reagents across four product lines: In Vitro Diagnostics (ECLIA immunoassay, HPLC hemoglobin, hematology, POCT immunofluorescence, and molecular diagnostics systems), Clinical Treatment equipment (high-flow humidifiers, HFCWO airway clearance, ESWT, video laryngoscopy, patient warming), Medical Aesthetic lasers (CO2 fractional, Q-switched Nd:YAG, diode, HIFU), and Consumer Health phototherapy devices. The company sells complete instrument-plus-reagent solutions to hospitals, labs, and clinics.
Is Lifotronic a public or private company?
Lifotronic is a public company. It is classified as public and is currently operating.
When was Lifotronic founded?
Lifotronic was founded in 2008. It employs 1,001 to 5,000 people.
Where is Lifotronic based?
Lifotronic is headquartered in Shenzhen, China, in the Asia region.
How does Lifotronic make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are IVD Reagents and Consumables.
Who are Lifotronic's main competitors?
Direct peers on record are Autobio Diagnostics, Snibe (Shenzhen New Industries Biomedical Engineering), Maccura Biotechnology and Mindray (Shenzhen Mindray Bio-Medical Electronics). Broad incumbents are Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Bio-Rad Laboratories, QuidelOrtho (Werfen/Quidel) and Abbott Diagnostics.
Does Lifotronic have an API?
No public API is recorded for Lifotronic.
What industry is Lifotronic in?
Lifotronic's product category is In Vitro Diagnostics & Medical Devices. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 3841.